Clinical Effectiveness and Safety of Vericiguat in Worsening Heart Failure with Reduced Ejection Fraction: A Single-center, Retrospective Analysis in Indian Patients
Background and Objective: In a tertiary care hospital in India, investigators evaluated the efficacy and safety of vericiguat, a new oral soluble guanylate cyclase stimulator in patients with worsening symptoms of heart failure and reduced ejection fraction (HFrEF). Methods: A retrospective assessme...
Saved in:
| Main Authors: | Pankaj Jariwala, Avvaru Guru Prakash, Poondru Rohith Reddy, Dilip Gude, Gururaj Pramod Kulkarni, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Anusha Jariwala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of the Practice of Cardiovascular Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpcs.jpcs_63_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vericiguat – possibly next weapon to overcome heart failure. Review of latest literature
by: Mikolaj Biskupski, et al.
Published: (2024-12-01) -
Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial
by: Alberto Esteban-Fernández, et al.
Published: (2025-01-01) -
New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01) -
Clinical profile, associated events and safety of vericiguat in a real‐world cohort: The VERITA study
by: Mario Galván Ruiz, et al.
Published: (2024-12-01) -
Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution
by: S. A. Boytsov, et al.
Published: (2023-05-01)